Evidence map›Paper›PMID 28718316›Full record

ArticleCNS oncology2017

Predictors of complications and readmission following spinal stereotactic radiosurgery.

Daniel Lubelski, Joseph E Tanenbaum, Taylor E Purvis, Thomas T Bomberger, Courtney Rory Goodwin, Ilya Laufer, Daniel M Sciubba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel LubelskiDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
Joseph E TanenbaumCleveland Clinic Center for Spine Health, Cleveland Clinic, Cleveland, OH, 44195, USA.
Taylor E PurvisDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
Thomas T BombergerCleveland Clinic Center for Spine Health, Cleveland Clinic, Cleveland, OH, 44195, USA.
Courtney Rory GoodwinDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
Ilya LauferDepartment of Neurosurgery, Memorial Sloan Kettering Hospital, New York, NY, 10022, USA.
Daniel M SciubbaDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Clinical and Translational Science Collaborative of ClevelandTL1TR000441 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$2.8M
NCATS NIH HHS TL1 TR000441NCATS NIH HHS TL1 TR002549NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

aimto identify preoperative factors associated with morbidity/mortality, hospital length of stay (LOS), 30-day readmission and operation rates following spinal stereotactic radiosurgery (SRS) for spinal tumors.

methodsThe American College of Surgeons National Quality Improvement Program was queried from 2012 to 2014 to identify patients undergoing SRS for spinal tumors. Logistic regression was performed to identify predictors.

results2714 patients were identified; 6.8% had major morbidity or mortality, 6.9% were readmitted within 30 days and 4.3% had a subsequent operation within 30 days. Age, BMI and American Society of Anesthesiologist (ASA) class were predictive of LOS. Major morbidity was predicted by age >80, BMI >35, high ASA, pretreatment functional dependence and baseline comorbidities. Predictors of operation within 30 days included preoperative steroid use, renal failure, BMI >35 and if the treatment was nonelective. DISCUSSION: 4-7% of patients undergoing SRS for spinal tumors have morbidity following the procedure. Factors predictive of morbidity, LOS, and subsequent operation included age, BMI, baseline comorbidities and functional status.

conclusionIdentification of preoperative patient-specific factors that are predictive of post-treatment outcome will aid in patient selection and patient counseling leading to greater patient satisfaction and hospital efficiency.

Indexed as

30 day readmissionAmerican College of Surgeons National Quality Improvement Programmajor morbidity and mortalitypredictorsspinal stereotactic radiosurgeryspinal tumors

Identifiers

PMID28718316
PMCPMC6009216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.